Navigation Links
Statement from the Consumer Healthcare Products Association on the Safety of Pediatric Over-the-Counter Medicines
Date:10/2/2007

WASHINGTON, Oct. 2 /PRNewswire-USNewswire/ -- Following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), in response to inaccurate and misleading media reports surrounding the U.S. Food and Drug Administration's upcoming joint meeting of the Nonprescription Drugs Advisory Committee and Pediatric Advisory Committee scheduled for October 18 and 19:

"CHPA and the makers of pediatric, over-the-counter cough and cold medicines are committed to helping ensure the safe use of cough and cold medicines in children. Our highest priority is the safe use of our medicines.

"Recent media reports have misstated the FDA's position on the use of pediatric cough and cold medicines, and these inaccurate reports may unnecessarily alarm and confuse parents who have successfully relied on these medicines to relieve the cough and cold symptoms in their children for generations.

"FDA has not called for a ban on medicines for children under 6. Rather, the agency has presented a variety of internal and external recommendations for discussion at the upcoming advisory committee meeting.

"FDA's press office issued a note to correspondents yesterday further clarifying that 'the Agency has not reached any final decisions as to actions to be taken in response to a citizen petition ... Any review document included in this package that contains specific recommendations should not be considered final decisions by the Agency. After hearing the recommendations of the advisory committee, FDA will determine the course of action.'

"Parents can continue to trust over-the-counter cough and cold remedies for their children. The instructions on these medications have always clearly directed parents to 'Ask a Doctor' before administering to children under two. We strongly encourage parents to adhere to the recommended dosing instructions for all medicines, recognizing that the vast majority of adverse events associated with their use are due to inadvertent overdosing and misuse. When used as directed, these medicines are safe and effective.

"Based on our commitment to the health and wellbeing of our nation's families, and because children under age 2 are most vulnerable to misuse of over-the-counter cough and cold medicines, we are recommending that labeling for children under 2 be strengthened to read, 'Do Not Use' versus 'Ask a Doctor.' We also are recommending that language be added to the label of OTC antihistamines to read, 'Do not use to sedate children.'

"In the coming months, we'll be launching a major educational campaign alerting parents and caregivers to use great caution when administering medicines to children. Specifically, we will target parents and caregivers of children under two, as well as pediatricians, to further underscore that over- the-counter medicines should not be given to children under two.

"As the makers of over-the-counter cough and cold medicines for children, we remain committed to ensuring parents and caregivers have the information they need to use these medicines safely and effectively, and that they have access to the very best possible medicines for their children.

Editor's note: FDA has posted some recommendations for parents (link: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript.cfm?show=6 8#8 ) in addition to issuing a note to correspondents further clarifying that no final decision on recommendations has been made.

CHPA is the 126-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplement products.

http://www.chpa-info.org

Contact: Elizabeth Funderburk

202.429.9260 (work)

202.256.5677 (cell)


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
2. Iodex goes to SmithKline Beecham consumer Healthcare
3. Consumer group seeks Sibutramine ban
4. Identifying What Consumers Look For On Food Stuff Labels
5. Consumers Becoming More Health Conscious Than Calorie Conscious
6. With More Appearance Conscious Consumers The Need For Slimming Products Is Rapidly Rising
7. Consumers of soft drinks to be more alert
8. Consumers Worried About Trans-Fats The Most
9. New Plastic Surgery Unit Set Up In Kolkata To Meet Ever-Increasing Consumer Demand
10. Health care system “Consumer friendly” by 207
11. Chocolate makers to be health wise and urge consumers to be too!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... ... states in the U.S. require dental technicians to be certified or obtain continuing ... industry, NADL created the “What’s In Your Mouth?” campaign to inform dentists and ...
(Date:2/7/2016)... ... February 07, 2016 , ... Women's Excellence staff, in all four locations, wore ... Wear Red Day is the first Friday each February and a day to bring ... in 3 deaths among women each year – more than all cancers combined. Go ...
(Date:2/7/2016)... ... 2016 , ... Dr. Todd Hobgood , certificated in ... surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, Kybella® ... for reduction of fat below the chin (aka the “double chin”). Medication side ...
(Date:2/6/2016)... ... ... US Sports Camps is proud to sponsor the Bay Area Disc Association's ... leaders, ultimate organizations, and coaches from around the US. The theme for this year’s ... of Youth and Education, describes this year YUCC as “an important conversation we must ...
(Date:2/6/2016)... , ... February 06, 2016 , ... Shark Finds ... announce the launch of a new DRTV campaign with Belly Bands. , Having a ... everything from sprays to puppy pads and find nothing works, get Belly Bands, ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Feb. 8, 2016   GS1 US will ... guide them through GS1 Standards implementation to address the ... Unique Device Identification (UDI) rule. Scott ... Beth Gibson , senior director industry development, medical devices, ... director, GS1 US --> Scott ...
(Date:2/8/2016)... Feb. 8, 2016 Nueterra, the ... specialized in the development of equity partnerships ... it has divided its interests between two ... Capital will continue the founding company,s private ... operate a national system of integrated provider ...
(Date:2/8/2016)... Pa. , Feb. 8, 2016   ... November Research Group (NRG),s pharmacovigilance technology services ... system-related consulting services and an Oracle Argus Specialized ... services to Life Sciences companies. ... and expands HighPoint,s life sciences capabilities and provides ...
Breaking Medicine Technology: